1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Generative AI in Drug Discovery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Generative AI in Drug Discovery Market, by Technology
8.1.1. Machine Learning
8.1.1.1. Market Revenue and Forecast
8.1.2. Reinforcement Learning
8.1.2.1. Market Revenue and Forecast
8.1.3. Deep Learning
8.1.3.1. Market Revenue and Forecast
8.1.4. Molecular Docking
8.1.4.1. Market Revenue and Forecast
8.1.5. Quantum Computing
8.1.5.1. Market Revenue and Forecast
9.1. Generative AI in Drug Discovery Market, by End User
9.1.1. Pharmaceutical & Biotechnology Company
9.1.1.1. Market Revenue and Forecast
9.1.2. Academic & Research Institution
9.1.2.1. Market Revenue and Forecast
9.1.3. Contract Research Organizations
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology
10.1.2. Market Revenue and Forecast, by End User
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology
10.1.3.2. Market Revenue and Forecast, by End User
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology
10.1.4.2. Market Revenue and Forecast, by End User
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology
10.2.2. Market Revenue and Forecast, by End User
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology
10.2.3.2. Market Revenue and Forecast, by End User
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology
10.2.4.2. Market Revenue and Forecast, by End User
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology
10.2.5.2. Market Revenue and Forecast, by End User
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology
10.2.6.2. Market Revenue and Forecast, by End User
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology
10.3.2. Market Revenue and Forecast, by End User
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology
10.3.3.2. Market Revenue and Forecast, by End User
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology
10.3.4.2. Market Revenue and Forecast, by End User
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology
10.3.5.2. Market Revenue and Forecast, by End User
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology
10.3.6.2. Market Revenue and Forecast, by End User
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology
10.4.2. Market Revenue and Forecast, by End User
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology
10.4.3.2. Market Revenue and Forecast, by End User
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology
10.4.4.2. Market Revenue and Forecast, by End User
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology
10.4.5.2. Market Revenue and Forecast, by End User
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology
10.4.6.2. Market Revenue and Forecast, by End User
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology
10.5.2. Market Revenue and Forecast, by End User
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology
10.5.3.2. Market Revenue and Forecast, by End User
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology
10.5.4.2. Market Revenue and Forecast, by End User
11.1. Insilico Medicine
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Atomwise Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BenevolentAI
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. XtalPi Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Numerate Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cyclica Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. BioSymetrics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Variational AI Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Variational AI Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. NVIDIA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
